For most people, once a year is the current rhythm. The CDC recommends a single updated COVID-19 vaccine each year for everyone aged six months and older, timed similarly to the annual flu shot. But that baseline shifts for older adults and people with weakened immune systems, who may benefit from additional doses within the same year. The reasoning behind this schedule has more to do with how quickly protection fades and how fast the virus changes than with any fixed biological rule.
The Current Schedule for 2025–2026
The CDC recommends one dose of the 2025–2026 COVID-19 vaccine for people ages six months and older, framed as an individual-based decision rather than a blanket mandate.1CDC. Staying Up to Date with COVID-19 Vaccines That language matters. Unlike the original vaccine rollout, when multi-dose primary series were standard, the current approach treats COVID vaccination more like the flu shot: get the latest version once a year and you are considered up to date.
This does not mean everyone needs exactly one dose per year with no exceptions. The recommendation accounts for most healthy adults and children, but the CDC and the Advisory Committee on Immunization Practices (ACIP) carve out specific groups who should get more. If you are 65 or older, or if you have moderate to severe immunocompromise at any age, the guidance changes substantially, and we will get into that shortly.
Why Protection Drops Off Within Months
The annual schedule exists because vaccine-induced protection does not hold steady for a full year. A large systematic review and meta-analysis published in JAMA Network Open found that vaccine effectiveness against infection dropped from roughly 53% one month after completing a primary series to about 14% by six months, and to about 9% by nine months.2JAMA Network Open. Evaluation of Waning of SARS-CoV-2 Vaccine–Induced Immunity: A Systematic Review and Meta-analysis That is a steep decline. By the time you are nine months out, the vaccine’s ability to prevent infection is close to negligible, though protection against severe illness tends to hold up somewhat better and longer than protection against infection alone.
This waning curve is the core reason health agencies settled on an annual update rather than a once-and-done approach or a longer interval. Antibody levels rise sharply after a shot, then gradually taper. The immune system retains some memory in the form of B cells and T cells that can reactivate during a real infection, which is why hospitalization and death rates stay lower even as infection protection fades. But for the best overall shield, a fresh dose each year restores that higher tier of antibody protection right before the winter respiratory season, when transmission tends to peak.
The Virus Keeps Changing, So the Vaccine Does Too
Waning immunity is only half the story. The other half is that SARS-CoV-2 mutates fast enough that last year’s vaccine may not match this year’s dominant strains. The current mRNA vaccines, Comirnaty and Spikevax, are updated to target the Omicron subvariant LP.8.1 and provide strong cross-protection against closely related strains like XFG, NB.1.8.1, and KP.3. But their effectiveness drops against variants that have drifted further from the target, such as XBB.1.5.3SpringerLink. SARS-CoV-2 variant dynamics and COVID-19 vaccine effectiveness during global epidemiological changes in mid-2025
This is exactly the same problem the flu vaccine has faced for decades. Influenza strains shift year to year, and the vaccine is reformulated each season to match the strains most likely to circulate. COVID has now entered the same pattern. Each annual update aims to give your immune system a head start against whatever is circulating, rather than training it for a variant that burned through the population a year or two ago. The JN.1-adapted vaccine, for instance, showed stronger immune responses against multiple circulating variants compared to the earlier XBB.1.5-adapted version, which underscores why rolling forward matters.3SpringerLink. SARS-CoV-2 variant dynamics and COVID-19 vaccine effectiveness during global epidemiological changes in mid-2025
If you have been putting off vaccination because you already got a shot a couple of years ago, the variant mismatch alone is a reason to consider getting the current formula. Your older antibodies still recognize some features of newer variants, but their fit is looser, and the protection gap widens as the virus accumulates more mutations.
Who Should Get More Than One Dose Per Year
For two groups, one annual dose is not enough. In October 2024, ACIP recommended that all adults 65 and older and all people aged six months and up with moderate or severe immunocompromise should receive a second dose of the 2024–2025 COVID-19 vaccine.4Centers for Disease Control and Prevention. Use of Additional Doses of 2024–2025 COVID-19 Vaccine for Adults Aged ≥65 Years and Persons Aged ≥6 Months with Moderate or Severe Immunocompromise For immunocompromised individuals specifically, the committee went further: they may receive three or more doses within the same vaccine year, based on shared decision-making with their doctor.
Why the difference? Older adults produce a weaker immune response to vaccination on average. Their antibodies still rise after a shot, but not as high and not for as long. A second dose later in the season helps re-boost protection during the months when the first dose’s effect is waning. For immunocompromised people, including those on certain cancer treatments, organ transplant recipients on anti-rejection medications, and people with advanced HIV, the immune response to a single dose can be minimal. Multiple doses are often needed just to reach the level of protection a healthy person gets from one.
If you fall into either group, the practical takeaway is to talk with your healthcare provider about timing. A common approach is to get one dose in the early fall and a second several months later, but the exact spacing depends on your medical situation. The key point is that the standard “one and done for the year” advice was not written with you in mind.
What If You Recently Had COVID
A natural infection does give your immune system real training against the virus, and when combined with vaccination, the result is what researchers call hybrid immunity. Studies confirm that hybrid immunity is more durable than either vaccination or prior infection on its own. But the numbers still show meaningful decline. One systematic review found that even with hybrid immunity, protection against Omicron reinfection was only about 50% at 26 weeks after vaccination. Among people with hybrid immunity who received a booster, protection started at around 81% but dropped to roughly 37% after just 16 weeks.5Vaccine. Durability of COVID-19 vaccine and infection induced immunity: A systematic review and meta-regression analysis
So while a recent infection does buy you some extra time, it does not make the vaccine unnecessary. The general guidance is to wait about three months after a confirmed COVID infection before getting your next vaccine dose. This is partly practical: your immune system is already activated, and an immediate dose would not add much on top of the natural response. It is also a comfort consideration, since side effects may be more pronounced if you vaccinate right on the heels of an infection.
That three-month window is a reasonable guideline for most people, not a hard rule. If you are immunocompromised, your doctor might recommend a shorter interval because your infection-induced immunity may be weaker. If a new variant has emerged that is substantially different from the one that infected you, earlier vaccination could make sense. The point is that having had COVID recently does not reset the clock to zero on needing the vaccine. It gives you a head start, but the head start shrinks faster than many people assume.
Timing Your COVID and Flu Shots
Since both the COVID and flu vaccines are now annual fall shots, a natural question is whether you can get them at the same visit. Research on coadministration shows that getting both on the same day is safe and does not increase vaccine-related side effects compared to getting either one alone.6PubMed Central. Immunogenicity and safety of coadministration of COVID-19 and influenza vaccination That is the good news. The caveat is that the same study found coadministration may slightly reduce the antibody response to the COVID vaccine compared to getting it on its own.
In practical terms, this means getting both shots at once is a perfectly reasonable choice for most people, especially if the alternative is skipping or delaying one of them. A slightly lower antibody peak is almost certainly better than no shot at all because you never got around to a second appointment. But if you are in a high-risk group where squeezing every bit of immune response out of your COVID vaccine matters, you might consider spacing the two shots a couple of weeks apart. There is no official mandate either way. The convenience of a single visit versus a marginally stronger antibody response is a judgment call you can make based on your own schedule and risk level.
Common Misconceptions About COVID Vaccine Frequency
One persistent belief is that getting “too many” boosters weakens the immune system or causes it to become less responsive over time. There is no evidence for this in the existing data. Each dose prompts a fresh round of antibody production and does not blunt the response to future doses. The confusion likely stems from the fact that each additional dose after the first produces diminishing incremental gains in peak antibody levels. That is a normal feature of immune responses to repeated exposure, not a sign of harm.
Another misconception is that if you had a strong reaction to a previous dose, such as fever, fatigue, or body aches, you are building up toward some kind of cumulative overload. Side effects from one dose do not predict worsening reactions to the next. In fact, some people report milder side effects with subsequent shots. The side effects themselves are signs that the immune system is responding, not signs of damage.
A third area of confusion involves whether the “original” vaccine series still matters. If you never completed a primary series years ago, you do not need to go back and make up missed doses from 2021 or 2022. Those older formulations targeted the original Wuhan strain, which is no longer circulating. The current recommendation is simply to get the latest updated vaccine. One dose of the 2025–2026 formula is considered sufficient for a healthy adult to be up to date, regardless of how many prior doses you have or have not received.1CDC. Staying Up to Date with COVID-19 Vaccines
Children and COVID Vaccine Schedules
For children, the schedule depends on age and prior vaccination history. Very young children, those between six months and four years, may still need a multi-dose series if they have never been vaccinated against COVID, because their immune systems need the extra exposure to build adequate protection. The number of doses can range from one to three depending on the vaccine brand and whether the child has received any COVID vaccine previously.
Children five and older generally follow the same one-dose annual update that adults do. Parents sometimes wonder whether a child who already had COVID still needs the vaccine. The same logic applies as for adults: infection provides some protection, but it wanes, and the vaccine adds a layer of defense that helps cover new variants. The CDC’s recommendation covers all children six months and older, with no carve-out for those with prior infection.1CDC. Staying Up to Date with COVID-19 Vaccines
How the Annual Model Might Evolve
The once-a-year framework is not locked in forever. It reflects the current pace of viral evolution and the durability of existing vaccines, both of which could change. If future vaccine technologies produce longer-lasting immunity, annual shots could become unnecessary. Nasal spray vaccines and next-generation designs that target more conserved parts of the virus are in development, and some aim to provide broader protection that does not erode as quickly when the virus mutates.
On the other hand, if a dramatically different variant emerges mid-year, as happened with the jump from Delta to Omicron, emergency updates and off-schedule booster campaigns could return. The annual cadence works for the relatively incremental drift that has characterized Omicron subvariants over the past couple of years, but a larger antigenic shift would demand a faster response. For now, the annual shot is the simplest, most evidence-supported approach for the average person. How tightly you want to follow that schedule depends on your age, health status, and tolerance for risk during respiratory season.